scholarly article | Q13442814 |
P50 | author | Geoffrey B Johnson | Q39051875 |
P2093 | author name string | Jeffrey L Platt | |
Gregory J Brunn | |||
Marlo K Bungum | |||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | toll-like receptor | Q408004 |
P304 | page(s) | 872-874 | |
P577 | publication date | 2005-02-28 | |
P1433 | published in | FASEB Journal | Q520194 |
P1476 | title | Conditional signaling by Toll-like receptor 4. | |
P478 | volume | 19 |
Q37741926 | Acute lung injury and ARDS in acute pancreatitis: mechanisms and potential intervention |
Q34789304 | An extracellular subtilase switch for immune priming in Arabidopsis. |
Q34720848 | Cleavage and activation of a Toll-like receptor by microbial proteases |
Q35881486 | Cleavage of PGRP-LC receptor in the Drosophila IMD pathway in response to live bacterial infection in S2 cells |
Q34035570 | DAMPening inflammation by modulating TLR signalling |
Q50774937 | Damage-associated molecular patterns (DAMPs) released after burn are associated with inflammation and monocyte activation. |
Q34803633 | Differential regulation of endothelial cell activation by complement and interleukin 1alpha |
Q36550370 | Echinococcus granulosus Antigen B binds to monocytes and macrophages modulating cell response to inflammation |
Q37316197 | Emerging role of Toll-like receptors in atherosclerosis |
Q34295352 | Endocytosis of collagen by hepatic stellate cells regulates extracellular matrix dynamics |
Q37273605 | Endogenous signals initiating inflammation in the injured nervous system |
Q36557953 | Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword? |
Q37013881 | Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease |
Q37448034 | Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner |
Q33938566 | Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses. |
Q38263533 | Fungal glycans and the innate immune recognition |
Q37971025 | Fungal surface and innate immune recognition of filamentous fungi |
Q33747297 | Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors |
Q58585910 | Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity |
Q47888806 | Heparan Sulfate Proteoglycans as Relays of Neuroinflammation. |
Q37983752 | Heparanase enzyme in chronic inflammatory bowel disease and colon cancer |
Q38080632 | Heparanase in inflammation and inflammation-associated cancer |
Q33761544 | Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice |
Q34876266 | Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice |
Q38985052 | Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy |
Q90183482 | Heparanase-2 protects from LPS-mediated endothelial injury by inhibiting TLR4 signalling |
Q60931211 | Heparanase: A Multitasking Protein Involved in Extracellular Matrix (ECM) Remodeling and Intracellular Events |
Q42587945 | Heparanase: From basic research to therapeutic applications in cancer and inflammation |
Q27025052 | Involvement of heparanase in atherosclerosis and other vessel wall pathologies |
Q43285983 | Isolated closed minor-muscle injury of the lower leg did not cause an obvious systemic immune response |
Q36542354 | Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression |
Q35102577 | Macrophage polarization in pancreatic carcinoma: role of heparanase enzyme |
Q37444400 | Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock |
Q37398627 | Mechanisms of Toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart. |
Q34110914 | Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells |
Q28396123 | Microglial Heparan Sulfate Proteoglycans Facilitate the Cluster-of-Differentiation 14 (CD14)/Toll-like Receptor 4 (TLR4)-Dependent Inflammatory Response |
Q33714011 | Modification of heparanase gene expression in response to conditioning and LPS treatment: strong correlation to rs4693608 SNP. |
Q59375743 | Monocyte-mediated T cell suppression by HIV-2 envelope proteins |
Q38704770 | Novel regulators of cardiac inflammation: Matricellular proteins expand their repertoire |
Q47377873 | Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression |
Q35646306 | Peptide 19-2.5 inhibits heparan sulfate-triggered inflammation in murine cardiomyocytes stimulated with human sepsis serum |
Q36841275 | Profiling of the dynamically alteredgene expression in peripheral nerve injury using NGS RNA sequencing technique |
Q37546836 | Protein kinase Cε-calcineurin cosignaling downstream of toll-like receptor 4 downregulates fibrosis and induces wound healing gene expression in cardiac myofibroblasts. |
Q51084635 | Relevance of meniscal cell regional phenotype to tissue engineering. |
Q38222891 | Repair of the Peripheral Nerve-Remyelination that Works. |
Q35091107 | Role of IL-1 receptor-associated kinase-M (IRAK-M) in priming of immune and inflammatory responses by nitrogen bisphosphonates |
Q41092935 | Role of TOPK in lipopolysaccharide-induced breast cancer cell migration and invasion. |
Q36885661 | Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14. |
Q36101233 | Significance of heparanase in cancer and inflammation |
Q39690963 | Surviving lethal septic shock without fluid resuscitation in a rodent model |
Q37023850 | TLR2 in murine atherosclerosis |
Q42004230 | The Role of Heparanase in the Pathogenesis of Acute Pancreatitis: A Potential Therapeutic Target |
Q35067827 | The ectodomain of the Toll-like receptor 4 prevents constitutive receptor activation |
Q36452903 | The potential of heparanase as a therapeutic target in cancer |
Q93206516 | The role of innate immunity in mucopolysaccharide diseases |
Q57090611 | Toll-Like Receptor Signaling Is Critical for Wallerian Degeneration and Functional Recovery after Peripheral Nerve Injury |
Q42183900 | Toll-Like Receptors and Myocardial Ischemia/Reperfusion, Inflammation, and Injury |
Q34321742 | Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis |
Q38196396 | Topographical changes in extracellular matrix: Activation of TLR4 signaling and solid tumor progression |
Q64961502 | Understanding the Role of Innate Immunity in the Response to Intracortical Microelectrodes. |
Q33770777 | Versatile role of heparanase in inflammation |
Q35232779 | Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury |
Search more.